RACHAEL POFF: Open Payments
NPI 1518523711 · DALEVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,882 in 144 payments from 18 companies in 2025. Trend: 2023 $2,985 · 2024 $1,414 · 2025 $2,882
Food & beverage: $2,882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $598 |
| Janssen Biotech, Inc. | 25 | $590 |
| Regeneron Healthcare Solutions, Inc. | 12 | $308 |
| PFIZER INC. | 10 | $227 |
| Ardelyx, Inc. | 12 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $139 |
| Ipsen Biopharmaceuticals, Inc | 5 | $132 |
| Aimmune Therapeutics, Inc. | 7 | $126 |
| Madrigal Pharmaceuticals | 7 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
Products named: TREMFYA, RINVOQ, DUPIXENT, IBSRELA, VELSIPITY, IQIRVO, ZENPEP, REZDIFFRA.
Industry payments across VA — which companies pay providers there.
